The professor clearly stated that they have equity funding to finish the trial. which will not dilute shareholder value. So no, it wont be a capital raising, and he said its not debt, so I'm confused, but more importantly we have funding and that was clearly stated.
Teva were a big pile sheat, so I'm glad they are gone. They were a generic company
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.043(2.50%) |
Mkt cap ! $2.102B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.69 | $1.64 | $1.212M | 730.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 31773 | 18 |
View Market Depth
| Last trade - 11.11am 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |